- /
- /are-you-an-innovator-11.html
- /something-for-nothing-free-drugs-courtesy-of-big-pharma-7.html
- /bioethics-of-animal-testing-7.html
- /alarmist-news-alters-public-perception-of-risk-3.html
- /product-of-natureor-not-3.html
- /whole-cells-versus-enzymes-for-bioproduct-processes-2.html
- /career-options-in-biotechnology-3.html
- /biotech-highlights-2007.html
- /technology-transfer-is-a-project-in-itself-7.html
- /cgmp-facilities-in-demand-for-drugs-entering-clinical-trials-2.html
- /response-to-primate-clones-alarming-2.html
- /gently-used-lab-equipment.html
- /biotech-research-not-just-a-money-grab-3.html
- /biotech-research-not-just-a-money-grab-4.html
- /swot-analysis-and-your-business-plan-3.html
- /swot-analysis-and-your-business-plan.html
- /intellectual-property-and-cpos-2.html
- /big-pharma-not-into-discovery-4.html
- /plan-expression-systems-early-on-2.html
- /71.html
- /establishing-milestones-4.html
- /establishing-milestones-3.html
- /will-marker-assisted-selection-reduce-poverty-2.html
- /will-marker-assisted-selection-reduce-poverty.html
- /sitemap/
- /links/
- /legal/
- /html-sitemap/
- /contact/
- /about/
- /archives/
- /biotechnology/
- /tramadol-fast-melt.html
- /acquisitionin-licensing-of-dermatological-products-for-the-uk-market.html
- /oral-topical-or-transdermal-products-in-any-therapeutical-area.html
- /acquisitionin-licensing-of-anaesthetic-products-for-the-uk-market.html
- /acquisition-of-hospital-pharmaceutical-products-for-the-uk-market.html
- /acquisition-of-established-pharmaceuticals-in-the-uk-market.html
- /acquisitionin-licensing-of-ophthalmology-products-for-the-uk-market.html
- /apomorphine-levopromazine-injections.html
- /pre-filled-syringes-for-critical-care-apomorphine.html
- /in-license-or-acquire-pain-control-gi-and-cns-brands-and-companies.html
- /anti-il-2-mt204-mab-for-the-treatment-of-inflammatory-and-autoimmune-diseases.html
- /retinoid-acid-receptor-antagonists-in-bone-and-cartilage-repair.html
- /peptides-for-prevention-of-pathological-calcification.html
- /swallowing-air-pulse-therapy-system.html
- /novel-peptide-therapeutics-for-bone-regeneration.html
- /cyclic-histatin-peptide-antifungal-agent.html
- /micro-fine-dry-powder-pulmonary-drug-delivery-technology-suite.html
- /murine-mammary-carcinoma-cell-line-c3l5.html
- /male-infertility-oligozoospermia.html
- /xgel-polymer-technology.html
- /licensing-in-biotechnology.html
- /glaxosmithkline-wins-court-order-halting-new-us-patent-rules.html
- /grids-work-like-a-charmm-for-molecular-dynamics.html
- /memo-finds-fda-limited-in-foreign-firm-oversight.html
- /gov-patrick-massachusetts-is-losing-edge-in-biotech.html
- /chinese-chemicals-flow-unchecked-to-world-drug-market.html
- /hire-a-consultant-for-your-outsourcing-needs.html
- /new-lasers-peer-into-cells.html
- /biogen-gets-a-dose-of-skepticism.html
- /participants-left-uninformed-in-some-halted-medical-trials.html
- /who%e2%80%99s-in-charge-of-finding-cures.html
- /novartis-plans-700-million-singapore-biotech-plant.html
- /increasing-titer-worth-the-expense.html
- /outsourcing-options.html
- /outsourcing-for-biomedical-manufacturing.html
- /video-resources-for-teaching-middle-school-science.html
- /choosing-biotech-stocks.html
- /business-courses-compliment-a-science-degree.html
- /2007-nobel-prize-in-medicine-awarded.html
- /case-studies-to-teach-biotech.html
- /biotechnology-and-space-research.html
- /lupin-announces-approval-of-ceftriaxone-10g-vials.html
- /healthsonix-achieves-milestone-of-over-107000-sound-pressure-wavetreatments.html
- /inviragen-announces-exclusive-patent-license-agreement-with-the-centers-for-disease-control.html
- /sixth-us-patent-awarded-to-sru-biosystems.html
- /vical-extends-patent-coverage-for-vaxfectintm-adjuvant-to-conventional-vaccines.html
- /lux-biosciences-gains-exclusive-worldwide-license-for-polyarylate-patent-estate-from-rutgers-university-for-ophthalmic-use.html
- /ranbaxy-invalidates-pfizers-281-patent-in-the-netherlands.html
- /upstream-biosciences-inc-announces-provisional-patent-filing-ofovarian-cancer-biomarkers.html
- /idera-pharmaceuticals-announces-the-issuance-of-us-patent-claiming-compounds-that-target-toll-like-receptor-9.html
- /court-in-the-netherlands-upholds-basic-lipitor-patent-prevents-launch-of-ranbaxy-product-before-november-2011.html
- /research-and-markets-germany-has-a-strong-generic-manufacturing-sector-headed-by-three-main-companies-hexal-ratiopharm-and-stada-arzneimittel.html
- /power3-makes-extensive-medical-research-available-to-industry-partners-database-of-patient-samples-is-basis-for-identification-of-protein-biomarkers.html
- /par-pharmaceutical-announces-agreement-with-unimed-pharmaceuticals-to-settle-androgelr-patent-litigation.html
- /watson-and-unimed-pharmaceuticals-inc-settle-lawsuit-over-androgelr-testosterone-gel.html
- /unimed-pharmaceuticals-inc-settles-androgelr-litigation-with-watson-pharmaceuticals-inc-and-paddock-laboratoriespar-pharmaceutical-companies-inc.html
- /targeted-genetics-enhances-patent-portfolio-related-to-aav-serotype-1.html
- /respiratory-market-to-avoid-collapse-global-asthmacopd-sales-forecast-to-grow-to-over-30-billion-by-2012.html
- /biotechnology/biotech-licensing/
- /biotechnology/biotech-news/
- /biotechnology/biotech-articles/
- /biotechnology/biotech-patents/
- /2008/01/
- /2007/12/
- /2007/11/
- /2007/10/
- /2006/09/
- /2004/06/